FTC Sues 'Middlemen' For Inflating Insulin Drug Prices
The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines
The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines